Unilife CEO Makes Open Market Purchase of $500,000 of Company Shares
23 Ottobre 2009 - 3:08PM
Marketwired
Unilife Medical Solutions Limited ("Unilife" or "the Company")
(ASX: UNI) (PINKSHEETS: UNIFF) today announced that its Chief
Executive Officer Alan Shortall has made open market purchases of
Company shares.
The total number of shares purchased on October 21, 2009 was
479,800 at an average price of A$1.026 per share. Mr. Shortall has
authorized his broker to purchase additional shares that will bring
the total number of shares purchased this week to in excess of
500,000 shares.
Mr. Shortall said that he has elected to purchase these shares
in the open market rather than participate in the recently
announced private placement.
"The reason I chose to purchase these shares via the open market
was to show our shareholders that I am standing by them in their
belief in the Company," Mr. Shortall said.
"I could have simply participated in the private placement and
obtained the shares at a discount to market and received the
benefit of the same options that the institutions received, but I
have instead chosen to show my allegiance to the Company and its
shareholders by purchasing additional shares in the open market. I
believe a direct market purchase is a truer reflection of my
genuine support for our Company and my confidence in our long term
prospects and world-class management team."
In considering his investment Mr. Shortall continued, "The
progress the Company has made during the last two years, and our
recent closing of the A$32.1 million private placement to
institutional investors, provides me with the confidence to state
that despite current economic conditions, I believe that Unilife
has never been in a better position, operationally or
financially."
About Unilife
Unilife Medical Solutions Ltd is an ISO 13485 certified company
that designs, develops and supplies innovative safety medical
devices. Listed on the Australian Securities Exchange (ASX: UNI)
since 2002, Unilife has FDA registered manufacturing facilities in
the US State of Pennsylvania and a proprietary portfolio of
clinical and prefilled safety syringes designed for use within
healthcare and pharmaceutical markets.
Shareholder / Analyst Enquiries: Australia Jeff Carter Phone: +
61 2 8346 6500 United States Stuart Fine Phone: + 1 908 469
1788
Grafico Azioni U and I Financial (QX) (USOTC:UNIF)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni U and I Financial (QX) (USOTC:UNIF)
Storico
Da Gen 2024 a Gen 2025
Notizie in Tempo Reale relative a U and I Financial Corporation (QX) (OTCMarkets): 0 articoli recenti
Più Unilife Medical Solution Articoli Notizie